Northwestern Mutual Wealth Management
SLNO

Northwestern Mutual Wealth Management’s Soleno Therapeutics SLNO Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1
Closed -$4 – 3513
2023
Q2 		$4 Hold
1
– – ﹤0.01% 3323
2023
Q1 		$2 Buy
+1
New +$2 ﹤0.01% 3330

Other funds holding SLNO

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Northwestern Mutual Wealth Management's SLNO Position: Q3 2023 in Review

Northwestern Mutual Wealth Management sold out of Soleno Therapeutics (SLNO) in Q3 2023, closing a stake of 1 share — an estimated $4 sold.

Northwestern Mutual Wealth Management first reported a position in SLNO in Q1 2023 and held it in 2 quarters. The position peaked at $4 in Q2 2023. 54 funds tracked by Wall St. Rank hold SLNO as of Q3 2023.

  • Northwestern Mutual Wealth Management reported no remaining Soleno Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1 Soleno Therapeutics share in Q3 2023, an estimated $4.
  • Northwestern Mutual Wealth Management first reported a position in Soleno Therapeutics in Q1 2023 and held it in 2 quarters.
  • Northwestern Mutual Wealth Management's Soleno Therapeutics position peaked at $4 in Q2 2023.
  • 54 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q3 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.